Turkiye Klinikleri Journal of Internal Medicine

.: ORIGINAL RESEARCH
Diyal-TR Kayıt Çalışmasındaki Hastaların Bir Yıllık Takibindeki Kardiyovasküler Olaylar: İnterim Analiz Bulguları
Cardiovascular Events in One-Year Follow-Up of the Patients in the Diyal-TR Registry: Interim Results
Pınar KIZILIRMAKa, Tevfik ECDERb, Kenan ATEŞc, Mustafa ARICId, Siren SEZERe, Hakan KAPTANOĞULLARIf, Turgay ARINSOYg
aAmgen Inc. İstanbul, TÜRKİYE
bDemiroğlu Bilim Üniversitesi Tıp Fakültesi, Nefroloji BD, İstanbul, TÜRKİYE
cAnkara Üniversitesi Tıp Fakültesi, Nefroloji BD, Ankara, TÜRKİYE
dHacettepe Üniversitesi Tıp Fakültesi, Nefroloji BD, Ankara, TÜRKİYE
eAtılım Üniversitesi Tıp Fakültesi, Nefroloji BD, Ankara, TÜRKİYE
fBiruni Üniversitesi Sağlık Hizmetleri Meslek Yüksekokulu, Diyaliz Bölümü, İstanbul, TÜRKİYE
gGazi Üniversitesi Tıp Fakültesi, Nefroloji BD, Ankara, TÜRKİYE
Turkiye Klinikleri J Intern Med. 2020;5(3):105-11
doi: 10.5336/intermed.2020-75401
Article Language: TR
Full Text
ÖZET
 Amaç: Kronik hemodiyaliz (HD) tedavisi uygulanan hastalar, başta kardiyak ve enfeksiyöz nedenler olmak üzere morbidite ve mortalitenin yüksek seyrettiği bir grubu temsil etmektedir. Bu ara analizde, Diyal-TR kayıt çalışmasındaki kronik HD tedavisi uygulanan hastalarda, 1 yıllık izlemde gözlenen kardiyovasküler (KV) olayların incelenmesi amaçlanmıştır. Gereç ve Yöntemler: Bu prospektif çalışmaya, 27 Ocak 2017-8 Şubat 2018 tarihleri arasında Türkiye'deki 93 merkezde son dönem böbrek hastalığı nedeni ile kronik HD tedavisine başlanan hastalar dâhil edilmiştir (n=2.461). Hastaların, 1 yıl süre ile 3 ay arayla yapılan vizitlerindeki klinik özellikleri incelenmiştir. KV ölüm, KV nedenle hastaneye yatış ve KV olaydan oluşan bileşik sonlanım noktası; yaş grubu, beden kitle indeksi (BKİ) (BKİ <23 kg/m2 veya ≥23 kg/m2), albümin düzeyi (<3,5 g/dL veya ≥3,5 g/dL) ve anemi durumuna göre karşılaştırılmıştır. Bulgular: Toplam 123 (%5,0) hastada, bileşik sonlanım noktasına ulaşılmıştır. Tüm nedenlere bağlı ölüm 80 (%3,3) hastada bulunmuştur. Bileşik sonlanım noktası ≥65 yaş hastalarda (%7,0), genç hastalara (%4,2) kıyasla anlamlı olarak daha fazla gerçekleşmiştir (p<0,01). BKİ'nin düşük olduğu hastalarda, yüksek olanlara kıyasla bileşik sonlanım noktası (%7,1'e karşı %4,5; p=0,02) ve KV ölüm (%2,1'e karşı %0,8; p=0,02) daha fazla gözlenmiştir. Hemoglobin düzeyi <10 g/dL olan hastalarda KV ölüm oranının (%2,2), hemoglobin düzeyi >12 g/dL olanlardakine (%0,6) kıyasla anlamlı olarak daha yüksek olduğu belirlenmiştir (p=0,03). Sonuç: Kronik HD tedavisi alan hastaların, 1 yıllık takibine ilişkin bu ara analizde, KV olayların başlangıçta ileri yaş, anemi ve düşük BKİ ile daha fazla görüldüğü ortaya konmuştur. Anemisi ve düşük BKİ olan kişilerde, KV ölümün de daha yüksek oranda gözlenmesi, kronik HD hastalarında anemiyi ve kısmen malnütrisyonu gidermeye yönelik stratejilerin gerekliliğine işaret etmektedir.

Anahtar Kelimeler: Böbrek diyalizi; kronik böbrek hastalığı; kayıt çalışması; anemi; malnütrisyon; kardiyovasküler olaylar
ABSTRACT
 Objective: Patients on chronic hemodialysis (HD) treatment represent a population with high morbidity and mortality, especially of cardiac and infectious origin. This interim analysis aimed to examine cardiovascular (CV) events observed during the one-year follow-up of patients on chronic HD treatment in Diyal-TR registry. Material and Methods: This prospective analysis included patients (n=2461) who were initiated chronic HD treatment due to end-stage renal disease in 93 centers across Turkey between 27 January 2017 and 8 February 2018. Data on patients' clinical characteristics were collected at every 3 months during their routine visits for one year. The composite endpoint of CV death, CV hospitalization, or CV event was compared by the age group, body mass index (BMI) (BMI <23 kg/m2 vs ≥23 kg/m2), albumin (<3.5 g/dL vs ≥3.5 g/dL), and anemia status of the patients. Results: The composite endpoint occurred in 123 (5.0%) patients. All-cause death was seen in 80 (3.3%) patients. The composite endpoint was significantly higher in ≥65-year-old patients (7.0%) than that in their younger counterparts (4.2%, p<0.01). Compared to those with high BMI, patients with low BMI had significantly higher rate of the composite endpoint (4.5% vs. 7.1%, p=0.02) and of CV death (0.8% vs. 2.1%, p=0.02).Patients with hemoglobin level of <10 g/dL had significantly higher CV death rate (2.2%) compared to that in those with hemoglobin level of >12 g/dL (0.6%, p=0.03). Conclusion: This interim analysis of patients on chronic HD treatment after oneyear follow-up showed higher rate of CV events with baseline advanced age, anemia, and low BMI. Increased rate of CV death in patients with anemia or low BMI seems to indicate the need for strategies that would reverse anemia nd -to some extent- malnutrition in patients receiving chronic HD treatment.

Keywords: Renal dialysis; chronic kidney disease; registries; anemia; malnutrition; cardiovascular events
REFERENCES:
  1. Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Official Journal of the International Society of Nephrology. Kidney International Supplements. 2013;3(1):1-150. https:// kdigo.org/ wp-content/ uploads/ 2017/02/ KDIGO_2012_CKD_GL.pdf
  2. Agarwal R. Defining end-stage renal disease in clinical trials: a framework for adjudication. Nephrol Dial Transplant. 2016;31(6):864-7.[Crossref] [PubMed] 
  3. Warwick G, Mooney A, Russon L, Hardy R. Clinical Practice Guideline: Planning, Initiating and Withdrawal of Renal Replacement Therapy. 6th ed. UK Renal Association; 2013. p.32. [Internet] https://renal.org/ sites/renal.org/files/planning-initiation-finalf506a031181561659443ff000014d4d8.pdf
  4. Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med. 1966;275(20):1089-92.[Crossref] [PubMed] 
  5. Rocco MV. Chronic hemodialysis therapy in the West. Kidney Dis (Basel). 2015;1(3):178-86.[Crossref] [PubMed] [PMC] 
  6. Lameire N, Van Biesen W, Vanholder R. Did 20 years of technological innovations in hemodialysis contribute to better patient outcomes? Clin J Am Soc Nephrol. 2009;4 Suppl 1:S30-40.[Crossref] [PubMed] 
  7. Wetmore JB, Collins AJ. Global challenges posed by the growth of end-stage renal disease. Ren Replace Ther. 2016;2:1-7.[Crossref] 
  8. Tsur N, Menashe I, Haviv YS. Risk factors before dialysis predominate as mortality predictors in diabetic maintenance dialysis patients. Sci Rep. 2019;9(1):10633.[Crossref] [PubMed] [PMC] 
  9. Tuğcu M, Kasapoğlu U, Şahin G, Apaydın S. The factors affecting survival in geriatric hemodialysis patients. Int J Nephrol. 2018;2018:5769762.[Crossref] [PubMed] [PMC] 
  10. Wagner M, Ansell D, Kent DM, Griffith JL, Naimark D, Wanner C, et al. Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis. 2011;57(6):894-902.[Crossref] [PubMed] [PMC] 
  11. Chandrashekar A, Ramakrishnan S, Rangarajan D. Survival analysis of patients on maintenance hemodialysis. Indian J Nephrol. 2014;24(4):206-13.[Crossref] [PubMed] [PMC] 
  12. Chertow GM, Johansen KL, Lew N, Lazarus JM, Lowrie EG. Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int. 2000;57(3):1176-81.[Crossref] [PubMed] 
  13. Kızılırmak P, Ecder T, Ateş K, Arıcı M, Sezer S, Kaptanoğulları H, et al. [Diyal-TR registry: investigation of clinical characteristics of the patients under chronic hemodialysis therapy in Turkey]. Turkiye Klinikleri J Intern Med. 2020;5(1):1-7. https://www.turkiyeklinikleri.com/article/en-diyal-tr-kayit-calismasi-turkiyede-kronik-hemodiyaliz-tedavisi-gormekte-olan-hastalarin-klinik-ozelliklerinin-arastirilmasi-86389.html
  14. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112-9.[Crossref] [PubMed] 
  15. Cozzolino M, Mangano M, Stucchi A, Ciceri P, Conte F, Galassi A. Cardiovascular disease in dialysis patients. Nephrol Dial Transplant. 2018;33(suppl_3):iii28-34.[Crossref] [PubMed] [PMC] 
  16. Lentine KL, Brennan DC, Schnitzler MA. Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol. 2005;16(2):496-506.[Crossref] [PubMed] 
  17. Luxardo R, Kramer A, González-Bedat MC, Massy ZA, Jager KJ, Rosa-Diez G, et al. The epidemiology of renal replacement therapy in two different parts of the world: the Latin American Dialysis and Transplant Registry versus the European Renal Association-European Dialysis and Transplant Association Registry. Rev Panam Salud Publica. 2018;42:e87.[Crossref] [PubMed] [PMC] 
  18. Ecder T, Utas C, Ates K, Bieber B, Robinson BM, Pisoni RL, et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS) in Turkey. Hemodial Int. 2017;21(3):430-9.[Crossref] [PubMed] 
  19. TND Böbrek Kayıt Kurulu. Türk Nefroloji Derneği 2017 Yılı Türk Böbrek Kayıt Sistemi Raporu; 2017. (Erişim tarihi: 8.4.2020) http://www.nefroloji.org.tr/folders/file/TND-2017-Kayit-Sistemi-Verileri.pdf
  20. Khan IH, Catto GR, Edward N, MacLeod AM. Death during the first 90 days of dialysis: a case control study. Am J Kidney Dis. 1995;25(2):276-80.[Crossref] [PubMed] 
  21. Eckardt KU, Gillespie IA, Kronenberg F, Richards S, Stenvinkel P, Anker SD, et al; ARO Steering Committee. High cardiovascular event rates occur within the first weeks of starting hemodialysis. Kidney Int. 2015;88(5):1117-25.[Crossref] [PubMed] [PMC] 
  22. de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009;302(16):1782-9.[Crossref] [PubMed] 
  23. Cozzolino M, Galassi A, Pivari F, Ciceri P, Conte F. The cardiovascular burden in end-stage renal disease. Contrib Nephrol. 2017;191:44-57.[Crossref] [PubMed] 
  24. Ahmadmehrabi S, Tang WHW. Hemodialysis-induced cardiovascular disease. Semin Dial. 2018;31(3):258-267.[Crossref] [PubMed] [PMC] 
  25. Cuevas X, García F, Martín-Malo A, Fort J, Lladós F, Lozano J, et al. Risk factors associated with cardiovascular morbidity and mortality in Spanish incident hemodialysis patients: two-year results from the ANSWER study. Blood Purif. 2012;33(1-3):21-9.[Crossref] [PubMed] 
  26. Ladhani M, Craig JC, Irving M, Clayton PA, Wong G. Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis. Nephrol Dial Transplant. 2017;32(3):439-49.[Crossref] [PubMed] 
  27. Badve SV, Paul SK, Klein K, Clayton PA, Hawley CM, Brown FG, et al. The association between body mass index and mortality in incident dialysis patients. PLoS One. 2014;9(12):e114897.[Crossref] [PubMed] [PMC] 
  28. Hong WP, Lee YJ. The association of dialysis adequacy, body mass index, and mortality among hemodialysis patients. BMC Nephrol. 2019;20(1):382.[Crossref] [PubMed] [PMC] 
  29. Drüeke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, et al; CREATE Investigators. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006;355(20):2071-84.[Crossref] [PubMed] 
  30. Kido R, Akizawa T, Fukuhara S. Haemoglobin concentration and survival of haemodialysis patients before and after experiencing cardiovascular disease: a cohort study from Japanese Dialysis Outcomes and Practice Pattern Study (J-DOPPS). BMJ Open. 2019;9(9):e031476.[Crossref] [PubMed] [PMC] 
  31. Stirnadel-Farrant HA, Karaboyas A, Cizman B, Bieber BA, Kler L, Jones D, et al. Cardiovascular event rates among hemodialysis patients across geographical regions-a snapshot from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int Rep. 2019;4(6):864-72.[Crossref] [PubMed] [PMC] 

.: Up To Date

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com